Tesamorelin 10mg

Tesamorelin is used to reduce excess stomach-area(abdominal) fat in HIV-infected adult patients with lipodystrophy. It is injected subcutaneously (under the skin) once a day. 

Tesamorelin is made with growth hormone-releasing factor (GRF).

Tesamorelin for injection is the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy.

Other Potential Benefits:

• Improved metabolic and cardiovascular health:By reducing visceral fat, the medication can improve lipid profiles (e.g., lower triglycerides and LDL cholesterol) and insulin sensitivity, thereby reducing the risk factors for metabolic syndrome and cardiovascular disease. It may also reduce liver fat in individuals with nonalcoholic fatty liver disease (NAFLD).
• Increased lean muscle mass and strength:Tesamorelin supports protein synthesis, which can lead to the preservation or increase of lean muscle mass and improved muscle density, especially when combined with diet and exercise.
• Enhanced cognitive function: Some studies suggest that tesamorelin may have positive effects on cognitive functions like memory and attention span, and may offer neuroprotective benefits, particularly in older adults with mild cognitive impairment.
• Better sleep quality and energy levels: Patients often report improvements in sleep quality, recovery time from physical activity, and overall vitality, which are associated with more optimal growth hormone levels.
• Improved bone health: Some research indicates potential benefits for increasing bone density, which could help in managing conditions like osteoporosis.